Home  >  News
Eppen_SpinPro_Apr26
you can get e-magazine links on WhatsApp. Click here
News
Specialised Therapeutics receives approval from Australia & Singapore for Zepzelca in combo with atezolizumab for advanced small cell lung cancer  April 21, 2026
Medprime solves manual pathology bottlenecks with the launch of Cilika AI for faster, scalable diagnostics  April 21, 2026
Rusan Pharma achieves global GMP milestone with PMDA Japan approval  April 21, 2026
Ampersand Biomedicines presents preclinical data on AMP-220, a gut-targeted IL-22 AND-Body therapeutic, at AAI 2026  April 21, 2026
ILS Hospitals partners with MedLern to transform healthcare workforce learning and elevate patient care standards  April 21, 2026
AskBio's Viralgen to supply commercial-scale drug product for REGENERATE-PD investigational gene therapy phase II trial for Parkinson’s disease  April 21, 2026
AstraZeneca introduces next-gen cardiologists through India Coronary Conquest 2026 with STEMI  April 21, 2026
Asahi Kasei initiates phase I trial of AK1940, a novel peptide candidate targeting autoimmune diseases  April 21, 2026
CDSCO declares 168 drug samples as NSQs, one as spurious in March  April 21, 2026
Orbicular's partner secures tentative US FDA approval for generic version of Ozempic  April 21, 2026
CitiusTech appoints Shyam Karunakaran as chief business officer – Payers & Platform Solutions  April 21, 2026
Medtronic completes acquisition of medical device company, CathWorks  April 21, 2026
Jeena Sikho Lifecare & Sat Kartar Life ink collaboration to build a technology-enabled Ayurveda healthcare ecosystem  April 21, 2026
Morepen Labs' Masulkhana facility clears US FDA inspection with Zero adverse observations  April 21, 2026
US FDA grants priority review to sBLA for Padcev+Keytruda as perioperative treatment for muscle-invasive bladder cancer regardless of cisplatin eligibility  April 21, 2026
Asahi Kasei completes acquisition of Aicuris to advance its global pharmaceutical strategy  April 21, 2026
AstraZeneca’s pivotal phase III MIRANDA trial of tozorakimab to treat COPD meets primary endpoint  April 21, 2026
China NMPA approves GSK’s Blenrep for treatment of 2L+ relapsed/refractory multiple myeloma  April 21, 2026
NPPA seeks market data to fix ceiling price of gentamicin formulation  April 21, 2026
 Back
 
Propak_Asia_2026
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram